What is the RVX.TO share price today?

This page shows the latest available Resverlogix Corp. (RVX.TO) price with its change against the prior close. Values are delayed or previous-close, not real-time.

Where is Resverlogix Corp. listed?

Resverlogix Corp. trades on the Toronto Stock Exchange under the symbol RVX.TO, ISIN CA76128M1086.

How large is Resverlogix Corp.?

Its market capitalisation is approximately 30.95M CAD, based on the latest available price and share count from our data provider.

Toronto Stock Exchange (TSX) · RVX.TO · ISIN CA76128M1086

Resverlogix Corp.

0.0900 CAD

0(0.00%)

Previous close · Sep 17, 16:10 ET

Data last updated: Sep 17, 16:10 ET (2 d ago)· Delayed exchange data

Resverlogix Corp. (RVX.TO) trades on the Toronto Stock Exchange and operates in the Biotechnology industry. Its market capitalisation is approximately 30.95M CAD. The company reports around 17 employees. Its ISIN is CA76128M1086. This page shows the latest available price, the day and 52-week ranges and an interactive chart. Quotes are delayed and are not intended for order execution.

Checking today's session…

Key facts

Exchange

Toronto Stock Exchange (TSX)

ISIN

CA76128M1086

Sector

Healthcare

Industry

Biotechnology

Country

Market cap

30.95M CAD

Employees

Previous close

0.09 CAD

Day range

0.09 – 0.09

52-week range

0.09 – 0.15

Volume

50-day average

0.10 CAD

200-day average

0.10 CAD

Asset type

Equity

About Resverlogix Corp.

Resverlogix Corporation is a biotechnology firm currently in advanced clinical development, concentrating on developing treatments for illnesses where existing medical solutions are inadequate. The company's leading therapeutic compound is apabetalone (RVX-208), a selective small molecule designed to inhibit bromodomain and extra-terminal proteins. This compound is presently undergoing pivotal Phase III clinical trials for patients afflicted with conditions such as cardiovascular disease, diabetes, various stages of kidney disease (including end-stage renal disease), and neurodegenerative disorders. Furthermore, Resverlogix Corp. has forged an alliance with Eversana Life Science Services, LLC to support the forthcoming commercial rollout of apabetalone as a treatment for COVID-19 across the United States and Canada. The company's main office is located in Calgary, Canada.

Company website

Frequently asked

What is the RVX.TO share price today?: This page shows the latest available Resverlogix Corp. (RVX.TO) price with its change against the prior close. Values are delayed or previous-close, not real-time.
Where is Resverlogix Corp. listed?: Resverlogix Corp. trades on the Toronto Stock Exchange under the symbol RVX.TO, ISIN CA76128M1086.
How large is Resverlogix Corp.?: Its market capitalisation is approximately 30.95M CAD, based on the latest available price and share count from our data provider.

All Resverlogix Corp. data comes from exchange and provider feeds for the Toronto Stock Exchange and is published for information, not as investment advice.

Real-time quotes are not licensed; prices are delayed or previous close, so they may lag the market by 15 minutes or a full session. Information only, not for trading. Where a figure is not covered by our licensed sources, the page says so rather than showing a substitute.